Skip to main content
Caplight Logo









Hone Bio

Hone Bio

Private
BristolHealthcare & Life Scienceshttps://hone.bio/

Last Round

Series A

Mar 16, 2021

Total Funding Raised

$6.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hone Bio is a biotechnology company developing a lipid nanoparticle (LNP) targeting technology for enhanced drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

LNP targetingtargeted drug deliverydrug delivery platformliver detargetingextrahapatic deliveryLNP deliveryprotein engineeringnon-viral deliveryfusion proteingene therapy deliverymRNA deliverylipid nanoparticleplatform licensingcancer immunotherapyCAR-T therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hone Bio Comparables

Compare Hone Bio with similar companies based on industry and business-model similarity.

Hone Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoVation Therapeutics
85%
Starna Therapeutics
77%
Genevant Sciences
76%

Hone Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 16, 2021
SeedNov 25, 2019

Hone Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 212% MoM, from 485 to 1.5K.

  • Mar 16, 2021

    $5M round led by Science Creates Ventures.

Hone Bio Filings

Explore SEC and related filing metadata, where available.

Hone Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hone Bio's valuation, stock price, and market status.

Is Hone Bio a public or private company?

Hone Bio is a private company.

What is the current stock price of Hone Bio?

Hone Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Hone Bio worth (valuation)?

Valuation information for Hone Bio is not publicly available.

Can I buy Hone Bio stock?

Hone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hone Bio's last funding round?

Hone Bio's most recent funding round was Series A on March 16, 2021.

Who are the main investors in Hone Bio?

Key investors in Hone Bio include Science Creates Ventures.

Will Hone Bio IPO soon?

No public IPO plans have been announced for Hone Bio.

How can I track Hone Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hone Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBristol
Employee Range4
Year Founded2017
Last FundingMar 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?